Clinical trials
Phase 3 Pancreatic Neoplasms trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2014 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2024 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 3 |
| Terminated | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 2 |
| Eli Lilly and Company | 2 |
| Incyte Corporation | 2 |
| Arcus Biosciences, Inc. | 1 |
| AstraZeneca | 1 |
| Hoffmann-La Roche | 1 |
| Immuneering Corporation | 1 |
| Merrimack Pharmaceuticals | 1 |
| NCIC Clinical Trials Group | 1 |
| NantCell, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 19 |
| Neoplasms | 4 |
| Adenocarcinoma | 3 |
| Endocrine Gland Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
| Digestive System Diseases | 2 |
| Digestive System Neoplasms | 2 |
| Endocrine System Diseases | 2 |
| Neoplasms by Site | 2 |
| Pancreatic Diseases | 2 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.